LLY Q2 2019 Earnings Report — Eli Lilly and Company Revenue & Financial Results | Market Cap Arena

Eli Lilly and CompanyLLY

Q2 2019 Earnings

Reported August 2, 2019

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q2 2019	Q1 2019	Q2 2018	QoQ Change	YoY Change
Revenue	$5.6B	$5.1B	$5.6B	10.7%	0.9%
Op. Income	$1.6B	$1.3B	$1.6B	24.7%	-4.6%
Gross Margin	80.0%	77.6%	77.9%	2.4pp	2.1pp
Net Margin	23.5%	83.3%	-4.7%	-59.8pp	28.2pp
EPS (Diluted)	$1.37	$4.31	$-0.25	-68.2%	648.0%
Free Cash Flow	$766M	-$89M	-$341M	958.0%	324.9%

Revenue Flow

Item	Amount
REVENUE	$5.6B
Cost of Revenue	$1.1B
GROSS PROFIT	$4.5B
R&D Expenses	$1.4B
Selling & Marketing	$0
General & Administrative	$1.5B
SG&A Expenses	$1.5B
Other Expenses	$0
Operating Expenses	$2.9B
Cost & Expenses	$4.1B
OPERATING INCOME	$1.6B
Interest Income	$19M
Interest Expense	$111M
Other Income/Expenses	-$107M
INCOME BEFORE TAX	$1.5B
Income Tax Expense	$139M
Net Income from Continuing Ops	$1.3B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.3B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.3B
D&A	$247M
EBIT	$1.6B
EBITDA	$1.8B
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$5.6B
Cost of Revenue	$1.1B
GROSS PROFIT	$4.5B
R&D Expenses	$1.4B
Selling & Marketing	$0
General & Administrative	$1.5B
SG&A Expenses	$1.5B
Other Expenses	$0
Operating Expenses	$2.9B
Cost & Expenses	$4.1B
OPERATING INCOME	$1.6B
Interest Income	$19M
Interest Expense	$111M
Other Income/Expenses	-$107M
INCOME BEFORE TAX	$1.5B
Income Tax Expense	$139M
Net Income from Continuing Ops	$1.3B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.3B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.3B
D&A	$247M
EBIT	$1.6B
EBITDA	$1.8B
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$1.3B
Depreciation & Amortization	$247M
Stock-Based Compensation	$80M
Deferred Income Tax	$61M
Other Non-Cash Items	$138M
Change in Working Capital	-$802M
OPERATING CASH FLOW	$1.1B
Capital Expenditure	-$285M
Acquisitions (Net)	-$45M
Purchases of Investments	-$86M
Sales/Maturities of Investments	$386M
Other Investing Activities	$46M
NET CASH FROM INVESTING	$61M
Net Debt Issuance	-$286M
Common Stock Repurchased	$0
Common Dividends Paid	-$598M
Other Financing Activities	-$2M
NET CASH FROM FINANCING	-$886M
FREE CASH FLOW	$766M
Net Change in Cash	$254M

Balance Sheet

Item	Amount
Cash & Equivalents	$2.3B
Short-Term Investments	$78M
Net Receivables	$5.6B
Inventory	$3.2B
Other Current Assets	$0
TOTAL CURRENT ASSETS	$13.5B
PP&E (Net)	$8.4B
Goodwill	$3.8B
Intangible Assets	$6.6B
Long-Term Investments	$1.9B
Tax Assets	$2.5B
Other Non-Current Assets	$2.1B
TOTAL NON-CURRENT ASSETS	$25.2B
TOTAL ASSETS	$38.7B
Account Payables	$1.2B
Short-Term Debt	$2.1B
Deferred Revenue	$0
Other Current Liabilities	$7.8B
TOTAL CURRENT LIABILITIES	$11.9B
Long-Term Debt	$13.7B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$2.4B
Other Non-Current Liabilities	$7.4B
TOTAL NON-CURRENT LIABILITIES	$24.0B
TOTAL LIABILITIES	$35.8B
Common Stock	$604M
Additional Paid-In Capital	$6.5B
Retained Earnings	$4.3B
Treasury Stock	-$62M
Accum. Other Comp. Income	-$5.6B
Other Equity	-$3.0B
TOTAL STOCKHOLDERS' EQUITY	$2.8B
Minority Interest	$77M
TOTAL EQUITY	$2.9B
TOTAL LIABILITIES & EQUITY	$38.7B
Total Debt	$16.3B
Net Debt	$14.0B